Union européenne -
français -
EMA (European Medicines Agency)
zejula
glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - agents antinéoplasiques - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.
Union européenne -
français -
EMA (European Medicines Agency)
akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - bénigne de la prostate tumeurs, résistant À la castration - agents antinéoplasiques - treatment of adult patients with prostate cancer.
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
zejula 100 mg capsules
glaxosmithkline ag - niraparibum - capsules - kapsel: niraparibum 100 mg à niraparibi tosilas monohydricus, color.: e 133, e 127, e 102, excipiens de la capsule. - onkologikum - synthetika
Canada -
français -
Health Canada
zejula capsule
glaxosmithkline inc - niraparib (niraparib tosylate) - capsule - 100mg - niraparib (niraparib tosylate) 100mg - antineoplastic agents
Canada -
français -
Health Canada
zejula comprimé
glaxosmithkline inc - niraparib (niraparib tosylate) - comprimé - 100mg - niraparib (niraparib tosylate) 100mg
Canada -
français -
Health Canada
akeega comprimé
janssen inc - niraparib (niraparib tosylate); acétate d'abiratérone - comprimé - 50mg; 500mg - niraparib (niraparib tosylate) 50mg; acétate d'abiratérone 500mg
Canada -
français -
Health Canada
akeega comprimé
janssen inc - niraparib (niraparib tosylate); acétate d'abiratérone - comprimé - 100mg; 500mg - niraparib (niraparib tosylate) 100mg; acétate d'abiratérone 500mg
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
zejula 100 mg comprimés pelliculés
glaxosmithkline ag - niraparibum - comprimés pelliculés - niraparibum 100 mg ut niraparibi tosilas monohydricus, cellulosum microcristallinum, lactosum monohydricum 34.66 mg, povidonum k 30, crospovidonum, silica colloidalis hydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (nigrum), pro compresso obducto. - onkologikum - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
akeega 50 mg/500 mg comprimés pelliculés
janssen-cilag ag - niraparibum, abirateroni acetas - comprimés pelliculés - niraparibum 50 mg ut niraparibi tosilas monohydricus 79.7 mg, abirateroni acetas 500 mg corresp. abirateronum 446 mg, hypromellosum, natrii laurilsulfas, lactosum 240.54 mg ut lactosum monohydricum, crospovidonum, cellulosum microcristallinum silicificatum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, glyceroli monocaprylocapras, talcum, natrii laurilsulfas, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 5.05 mg. - cancer de la prostate - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
akeega 100 mg/500 mg comprimés pelliculés
janssen-cilag ag - niraparibum, abirateroni acetas - comprimés pelliculés - niraparibum 100 mg ut niraparibi tosilas monohydricus 159.4 mg, abirateroni acetas 500 mg corresp. abirateronum 446 mg, hypromellosum, natrii laurilsulfas, lactosum 240.54 mg ut lactosum monohydricum 253.2 mg, crospovidonum, cellulosum microcristallinum silicificatum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, glyceroli monocaprylocapras, talcum, natrii laurilsulfas, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 5.06 mg. - cancer de la prostate - synthetika